Does neuroimaging research examining the pathophysiology of posttraumatic stress disorder require medication-free patients?

Ruth A. Lanius, Chris R. Brewin, J. Douglas Bremner, Judith K. Daniels, Matthew J. Friedman, Israel Liberzon, Alexander McFarlane, Paula P. Schnurr, Lisa Shin, Murray Stein, Eric Vermetten

Research output: Contribution to journalReview article

31 Scopus citations

Abstract

Background: In an attempt to avoid unknown influence, most neuroimaging studies examining the pathophysiology of posttraumatic stress disorder (PTSD) exclude patients taking medications. Here we review the empirical evidence for relevant medications having a confounding effect on task performance or cerebral blood flow (CBF) in this population. The evidence for potentially confounding effects of psychotherapy in PTSD are also discussed. Methods: The literature that we reviewed was obtained through a PubMed search from 1980 to 2009 using the search terms posttraumatic stress disorder, PTSD, psychotropic medications, neuroimaging, functional magnetic resonance imaging, positron emission tomography, cerebral blood flow, CBF, serotonin-specific reuptake blocker, benzodiazepine, ketamine, methamphetamine, lamotrigine and atypical antipsychotic agents. Results: The empirical evidence for relevant medications having a confounding effect on task performance or CBF in relevant areas remains sparse for most psychotropic medications among patients with PTSD. However, considerable evidence is accumulating for 2 of the most commonly prescribed medication classes (serotonin-specific reuptake inhibitors and benzodiazepines) in healthy controls. Compelling data for the potentially confounding effects on brain areas relevant to PTSD for psychotherapeutic interventions are also accumulating. Conclusion: Neuroimaging studies examining the pathophysiology of PTSD should ideally recruit both medicated (assuming that the medication treatment has not resulted in the remission of symptoms) and unmedicated participants, to allow the findings to be generalized with greater confidence to the entire population of patients with PTSD. More research is needed into the independent effects of medications on task performance and CBF in regions of interest in PTSD. Neuroimaging studies should also take into account whether patients are currently engaged in psychotherapeutic treatment.

Original languageEnglish (US)
Pages (from-to)80-89
Number of pages10
JournalJournal of Psychiatry and Neuroscience
Volume35
Issue number2
DOIs
StatePublished - Mar 2010

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Does neuroimaging research examining the pathophysiology of posttraumatic stress disorder require medication-free patients?'. Together they form a unique fingerprint.

Cite this